| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,384 | 0,472 | 20:17 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Cambridge Cognition - COG to present at Mello 2026 | - | RNS | ||
| 28.05. | Cambridge Cognition - Launch of brain health study with Oura | - | RNS | ||
| 21.05. | Cambridge Cognition - Result of AGM | - | RNS | ||
| 24.04. | Cambridge Cognition - Posting of Annual Report & Notice of AGM | - | RNS | ||
| 13.04. | Cambridge Cognition - Results for the year ended 31 December 2025 | - | RNS | ||
| 07.04. | Cambridge Cognition - Notice of Results | - | RNS | ||
| 07.04. | Cambridge Cognition - Appointment of Nominated Adviser and Joint Broker | - | RNS | ||
| 11.03. | Cambridge Cognition - Monument Therapeutics MT1988 First Patient Dosed | - | RNS | ||
| CAMBRIDGE COGNITION Aktie jetzt für 0€ handeln | |||||
| 17.02. | Cambridge Cognition Holdings plc: Cambridge Cognition Partners With Ivory to Scale Early Cognitive Screening With CANTAB Pathway in India | 370 | Business Wire | Cambridge Cognition Holdings plc ("Cambridge Cognition") (AIM: COG), the neuroscience technology company specialising in digital cognitive assessments, and Ivory, a venture-backed brain health company... ► Artikel lesen | |
| 16.02. | Cambridge Cognition's India deal could be a game changer | 2 | The Armchair Trader | ||
| 16.02. | AIM WINNERS & LOSERS: Cambridge Cognition rises on deal with Ivory | 1 | Alliance News | ||
| 16.02. | Cambridge Cognition - Commercialisation Agreement | - | RNS | ||
| 09.02. | Cambridge Cognition - Change of Joint Broker | - | RNS | ||
| 19.01. | Cambridge Cognition reports rebound in commercial momentum | 1 | Sharecast | ||
| 19.01. | Cambridge Cognition - Trading Update | 1 | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 57,47 | -3,15 % | BrightSpring stockholders price 15M share offering at $58.75 | ||
| FRESENIUS | 36,670 | +1,97 % | Während Merck, Amgen, Novo Nordisk und Fresenius Milliarden bewegen, wächst die Fantasie im Zelltherapie-Sektor | ||
| SIEMENS HEALTHINEERS | 34,650 | +3,43 % | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,740 | +4,78 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung gemäß Artikel 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014 und Artikel 2 Abs. 1 der Delegierten... ► Artikel lesen | |
| VERU | 4,870 | +116,44 % | VERU INC. - 8-K, Current Report | ||
| BILLIONTOONE | 105,16 | +6,91 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| GENEDX | 56,37 | +6,10 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| ALIGNMENT HEALTHCARE | 14,840 | +8,80 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| CARL ZEISS MEDITEC | 26,640 | +1,52 % | EQS-DD: Carl Zeiss Meditec AG: Peter Kameritsch, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.05.2026 / 14:57... ► Artikel lesen | |
| UNITEDHEALTH | 340,20 | +4,68 % | Aktien New York Ausblick: Techwerte unter Druck nach KI-Ausblick von Broadcom | NEW YORK (dpa-AFX) - Ein enttäuschender Ausblick des Chipkonzerns Broadcom dürfte am Donnerstag für Moll-Stimmung an der Technologiebörse Nasdaq sorgen. Der Broker IG taxierte den viel beachteten Branchenindex... ► Artikel lesen | |
| HEARTFLOW | 28,910 | +0,21 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| PROGYNY | 25,860 | +2,95 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| GERRESHEIMER | 25,900 | -1,52 % | Aktien - Shortseller-Positionen: Delivery Hero, Gerresheimer, GFT, Hensoldt, Nagarro, Redcare, Renk, RTL | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 10,420 | +16,69 % | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen | |
| BUTTERFLY NETWORK | 5,175 | +12,99 % | Butterfly Network adds former B. Braun CEO to board |